KRAS and neoplasm: Remarkably, pro‐invasive tumors showed increased KRAS signaling in comparison to non‐pro‐invasive (more expression of genes upregulated by KRAS and less of genes downregulated by KRAS), suggesting that this pathway may be an important axis implicated in the tumor predisposition to acquire a more malignant phenotype after antiangiogenic therapy.